Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.91 USD
−22.16 M USD
73.11 K USD
About Evaxion Biotech A/S
Sector
Industry
CEO
Christian Kanstrup
Website
Headquarters
Hoersholm
Founded
2008
FIGI
BBG00YTSS733
Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.